Elon Musk recently announced the successful implantation of Neuralink’s wireless brain chip in a human, showing promising initial results with increased neuron activity. Prior to Neuralink, other companies explored similar brain implants.
Last May, the FDA granted approval for Neuralink to test the brain chip on humans, leading to a six-year study involving 64 thin threads inserted into the brain’s movement control area. The chip, powered wirelessly, sends brain signals to an app, allowing users to control devices through thoughts, a concept Musk dubbed “telepathy.”
Despite success, Neuralink faced criticism for animal testing-related deaths. While the FDA approved human testing in 2023, ongoing investigations persist.
Prof. Tara Spiers-Jones sees potential for neurological diseases but notes invasive surgery and experimental stages. Musk envisions aiding those with disabilities, drawing parallels to Stephen Hawking’s communication challenges.
Competing with other companies, Neuralink’s prominence grows. Precision Neuroscience offers a thin brain tap for stroke patients. Recent studies highlight brain implants aiding communication.
Prof. Anne acknowledges Neuralink’s human trial success but urges caution, emphasizing long-term assessment. Elon Musk’s claim awaits independent verification, and Neuralink’s details remain undisclosed.
A Swiss company also achieved breakthroughs, enabling a disabled person to walk through brain and spinal cord electronic implants.